Items where Author is "Ulloa-Montoya, Fernando"

Group by: Item Type | No Grouping
Jump to: Article
Number of items: 2.

Article

Dizier, Benjamin and Callegaro, Andrea and Debois, Muriel and Dreno, Brigitte and Hersey, Peter and Gogas, Helen J. and Kirkwood, John M. and Vansteenkiste, Johan F. and Sequist, Lecia V. and Atanackovic, Djordje and Goeman, Jelle and van Houwelingen, Hans and Salceda, Susana and Wang, Fawn and Therasse, Patrick and Debruyne, Channa and Spiessens, Bart and Brichard, Vincent G. and Louahed, Jamila and Ulloa-Montoya, Fernando A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer. Clinical Cancer Research (2019), 26 (7) pp. 1725-1735. ISSN 1078-0432

Dreno, Brigitte and Thompson, John F and Smithers, Bernard Mark and Santinami, Mario and Jouary, Thomas and Gutzmer, Ralf and Levchenko, Evgeny and Rutkowski, Piotr and Grob, Jean-Jacques and Korovin, Sergii and Drucis, Kamil and Grange, Florent and Machet, Laurent and Hersey, Peter and Krajsova, Ivana and Testori, Alessandro and Conry, Robert and Guillot, Bernard and Kruit, Wim H J and Demidov, Lev and Thompson, John A and Bondarenko, Igor and Jaroszek, Jaroslaw and Puig, Susana and Cinat, Gabriela and Hauschild, Axel and Goeman, Jelle J and van Houwelingen, Hans C and Ulloa-Montoya, Fernando and Callegaro, Andrea and Dizier, Benjamin and Spiessens, Bart and Debois, Muriel and Brichard, Vincent G and Louahed, Jamila and Therasse, Patrick and Debruyne, Channa and Kirkwood, John M MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Oncology (2018), 19 (7) pp. 916-929. ISSN 14702045

This list was generated on Mon Dec 5 12:37:42 2022 UTC.